Loading clinical trials...
Loading clinical trials...
Expectation and Response to Levodopa & Acupuncture in Parkinson's Disease
To investigate how levodopa and acupuncture affect fatigue and muscle function in people who suffer from Parkinson's disease. Subjects may choose to participate in levodopa or acupuncture part, or both. Study procedures include an exercise protocol, transcranial magnetic stimulation (a non-invasive type of brain stimulation that cause small muscle twitch), a blood draw, and personality surveys.
Subjects will answer surveys, have their blood drawn, undergo TMS and perform an exercise. The TMS/exercise task will measure fatigue and muscle response. The surveys will describe personality and measure fatigue. The CTRC will do genotype studies on the blood to look for genetic differences. Each subject is eligible to receive both study treatment types (levodopa and acupuncture). Depending upon the study treatment type they choose, each subject will be randomly assigned to one of six possible subject groups: Ia. Full expectancy; levodopa: Subjects will be told that they are taking levodopa. Ib. Half expectancy; levodopa: Subjects will be told that they have 50% chance of receiving levodopa or placebo. Ic. No expectancy; levodopa: Subjects will be told that they are receiving placebo levodopa. IIa. Full expectancy; acupuncture: Subjects will be told that they are receiving real acupuncture. IIb. Half expectancy; acupuncture: Subjects will be told that they have 50% chance of receiving real or sham-acupuncture. IIc. No expectancy; acupuncture: Subjects will be told that they are receiving sham-acupuncture. Subjects will attend four visits for the levodopa part and/or three visits in the acupuncture part. On the first visit, subjects will answer questionnaires and have samples of their blood collected. On the other visits, subjects will undergo TMS while they perform a repetitive exercise task. Subjects will then either wait for 30 minutes or receive the investigative intervention that they have been randomly assigned for that particular visit, and then repeat the TMS/exercise task.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Oregon Health & Science University
Portland, Oregon, United States
Start Date
August 1, 2005
Primary Completion Date
February 1, 2007
Completion Date
February 1, 2007
Last Updated
May 5, 2015
63
ACTUAL participants
Levodopa or acupuncture
BEHAVIORAL
Lead Sponsor
Oregon Health and Science University
Collaborators
NCT02119611
NCT07310264
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07216976